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ABSTRACT  
Solanum incanum Linnaeus is traditionally used for treatment of pain and other ailments. But there is no scientific evidence on its analgesic 
activity to-date. Thus the aim of this study was to evaluate the analgesic activities of 80% methanol leaf extract of S.incanum in mice. After 
extraction of the crude using 80% methanol, S.incanum extract was evaluated for analgesic activity in hot plate test and acetic-acid induced 
writhing test. Mice were randomly assigned to different groups and treated with 100, 200 and 400 mg/kg doses of the extract and reference 
control groups (morphine 5mg/kg and Aspirin 150 mg/kg) and negative control were treated with 2% tween 80. In the hot-plate method, all 
doses of the extract and the standard drug of morphine prolonged the reaction time significantly (p<0.05, or p<0.01 or p<0.001) as compared to 
negative control throughout the observation period. Prolongation of reaction time produced by 100mg/kg of the extract was low er (p<0.01) 
compared to morphine, 200mg/kg, and 400mg/kg at 90 and 120 min. However, middle and higher dose exerts comparable result at 30, 60 and 
90and 120 min in relation to the standard drug. In addition 80% methanol extract of S.incanum showed a significant protection (p<0.05) 
against acetic acid induced writhing compared to negative control. The extract produced a significant analgesic activity with 55.6, 38.2 and 
44.8% inhibition of number of writhing at 100, 200 and 400 mg/kg dose levels, respectively. In conclusion, this study clearly suggests that 80% 
methanol leaf extract of S. incanum is endowed with central and peripheral analgesic activity. Hence, the findings collectively uphold the 
traditional use of the plant for pain treatment. 
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Pain could be defined as an unpleasant sensory and 
emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage.1,2 The 
intensity of pain is difficult to measure and an individual’s 
perception of pain depends on the individual’s emotional 
state, circumstances under which the pain was acquired, and 
whether it is perceived as a threatening signal.3 Pain is an 
enormous problem globally and estimates suggest that 20% 
of adults suffer from pain globally and 10% are newly 
diagnosed with chronic pain each year. According to a 2014 
study on the global burden of chronic pain, at least 10% of 
the world’s population is affected by a chronic pain 
condition and every year, an additional 1 in 10 people 
develops chronic pain.4 The lifetime prevalence for LBP 
among Africans (47%) was also found to be considerably 
higher than the estimates (38.9%) reported and the lifetime, 
annual and point prevalence of LBP was estimated to be 
higher among African adults compared to African children 
and adolescents.5 Although there is no study on the 
prevalence of pain in Ethiopia, a population based urban 
study has shown that prevalence of primary headache 
disorders was found to be 21.6% and that for migraine was 
10%.6 
Currently, the drugs used to relieve pain are either narcotics 
such as opioids or nonnarcotic such as salicylates. However, 
use of NSAIDs is associated with a number of adverse effects 
such as gastric irritation and gastric ulcer, alterations in 
renal function, effects on blood pressure, hepatic injury, and 
platelet inhibition, which may result in increased bleeding.7 
The issue of tolerance and dependence induced by opiates is 
also a major challenge in the use of narcotics for pain 
management. Moreover, despite the progress that has made 
in past in the development of pain therapy there is a need for 
effective and potent analgesic since about 40% of the 
respondents suffering from chronic pain are not satisfied 
with the treatment.8 Therefore, analgesic drugs lacking those 
effects are being searched all over the world as alternatives 
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to NSAIDs and opiates. During this seeking process, the 
investigation of the efficacy of plant-based drugs used in the 
traditional medicine have been paid great attention because 
herbal medicines are deemed to be safe, have good efficacy, 
are culturally accepted and have lesser side effects than the 
synthetic drugs.9,10 Because of potential side effects and 
inefficiency of chemical and synthetic drugs, application of 
complementary medications, particularly medicinal plants, 
for pain management is increasing.11 Some of herbs and 
medicinal plants proved to be scientifically used for the 
treatment:  Aloe vera, Cordia verbenaceae, Curcuma longa, 
Curcuma longa, Kalanchoe pinnata, Schinus terebinthifolius.12  
The experimental plant Solanum incanum L is traditionally 
used for pain managenment in Ethiopian folklore medicine. 
Solanum incanum Linnaeus or Sodom/bitter apple (English), 
Embouy (Amharic), Hiddi (Afan Oromo) is a perennial, wild 
shrub like herb that grows up to 1.8 m in height that belongs 
to Solanaceae family which grows in many regions of Africa, 
Middle East and Far East Asia.13 In Africa the whole part 
herb is used as a folklore remedy for sore throat, angina, 
stomach-ache, colic, headache, relieve of painful 
menstruation, liver problems and pain caused by 
onchocerciasis, pleurisy, pneumonia and rheumatism. The 
plant parts are also widely used to alleviate skin problems, 
such as infections, whitlow, ringworm, burns, sores, rashes, 
wounds, warts, carbuncles, ulcers, inflammations and benign 
tumors. Alternatively, the roots are chewed or its infusions 
applied externally on scarifications. Leaves parts are also 
used for washing painful areas, while in some cases they are 
burnt and the ash mixed with fat for use as an ointment.14, 15 
In addition, fresh leaves juice traditionally are used in 
Ethiopia for their wound healing activity.16 Moreover, there 
is evidence that the root part of S.incanum is endowed with 
analgesic and wound healing activities in animal models.17 
Phytochemical studies indicate whole part of the herb 
contains substances such as steroidal alkaloids, glycol-
alkaloids, antioxidants (flavonoids and chlorogenic), and 
saponins which are thought to have analgesic activity in 
different studies.18 Thus the main aim of this study is to 
evaluate analgesic activities of 80% methanol leaf extract of 
Solanum incanum L. in mice. 
2. MATERIALS AND METHODS  
2.1. Chemicals, drugs and reagents 
Distilled water (DW), Morphine (Ethiopian Pharmaceutical 
Manufacturing Factory, Ethiopia), absolute methanol 
(Indenta chemicals, India) and Glacial acetic acid (Sigma – 
Aldrich laborchemikalien, Germany), Aspirin (Ethiopian 
Pharmaceutical Manufacturing Factory, Ethiopia) obtained 
from the respective vendors were used in the experiment. 
2.2. Plant material  
Fresh leaves of Solanum incanum was collected from 
Bishoftu town, Oromia region which is 60 km away from 
Addis Ababa, Ethiopia in January 2019. The plant material 
was then wrap with plastic shit and transport to 
Pharmacology laboratory at the department of 
Pharmacology and Clinical Pharmacy, School of Pharmacy, 
College of Health Sciences, Addis Ababa University. 
Identification and authentication of the plant material was 
done by taxonomist and Voucher specimen (Collection 
Number BA/001) at national herbarium, College of Natural 
and Computational Sciences, Addis Ababa University, Addis 
Ababa, Ethiopia. The collected plant material was identified 
to eliminate any dead material and then dried at room 
temperature under shaded area without exposing to direct 
sunlight. The dried plant materials were then broken in to 
small pieces using mortar and pestle and then prepared for 
extraction. 
2.3. Experimental animals  
The experiment was performed using Swiss albino mice of 
either sex weighing (20-30g) obtained from animal house of 
Addis Ababa University, College of Health Sciences, School of 
Pharmacy. The animals were maintained under standard 
laboratory condition (room temperature with 12:12 hour 
light–dark cycle) and were provided with the standard 
animal feed and water ad libitum. Animals were also 
acclimatized to the laboratory conditions for 7 days before 
the commencement of the actual experiment. All animals in 
this study were handled in accordance with the 
internationally accepted standard guidelines for use of 
animals (OECD, 2008) and the protocol was approved by the 
School of Pharmacy Ethics committee.19 
2.4. Extraction  
The 80% methanol extract was prepared using maceration 
technique by soaking 150 g dry powder of S.incanum leaves 
with 80% methanol solution (1.8 L) in Erlenmeyer flask for 
72 h at room temperature. The mixtures were filtered 
through gauze and then by Whatman No. 1 filter paper. The 
mark was re-extracted successively two times for a total of 6 
days. The filtrates were combined and the solvent was 
removed by evaporation using a rotary evaporator (Buchi 
labortechnik, Switzerland) at 40 °C under reduced pressure. 
The remaining solvent was then removed in a lyophilizer 
(Delvac, India) to obtain a complete dry powdered residue. 
The resulting dry extract was weighed and the total yield 
was found to be 22%.  The dried extracts were reconstituted 
with 2% tween 80 for oral administration. 
2.5. Acute toxicity test  
Acute toxicity test was performed based on the limit test 
recommendations of OECD Guideline 425 (OECD, 2008).19 
On day one, a single female mouse was fasted for 3-4 h and 
given 2000 mg/kg of the extract orally. The mouse was then 
kept under strict observation for any physical or behavioral 
changes within 24 h, with special attention during the first 4 
h. Following the results from the first mouse, other four 
female mice were fasted for 3-4 h and administered a single 
dose of 2000 mg/kg. They were then observed in the same 
manner. The observation continued for further 14 days for 
any signs of toxicity. Observations include changes in skin 
and fur, eyes and mucous membranes, and also respiratory, 
circulatory, autonomic and central nervous systems, and 
somatomotor activity and behavior pattern. 
2.6. Grouping and dosing of animals 
Mice were randomly divided into five groups of six mice per 
group. Group I served as negative control and received 
vehicle (2% of Tween 80, P.O., 0.1 ml/10 g). Group II served 
as positive control and treated with standard drugs; 
morphine (5mg/kg, I.P.) for hot plate test and (4 mg/kg, S.C.) 
Aspirin (30 mg/kg, P.O.) for writhing test. Group III-V were 
treated with the extract at doses of 100 mg/kg, 200 mg/kg 
and 400 mg/kg, respectively. Doses were selected based on 
acute toxicity study. From the acute toxicity studies as per 
OECD (2008) guidelines, after having considered the safety 
of the plant, 1/10th of the maximum dose (2000 mg/kg) was 
considered as a middle dose. Half and double of the middle 
dose were considered as the low and high dose, respectively. 
Dose of Morphine (5 mg/kg) and Asprin (30mg/kg) was 
selected based on previous studies. The test doses were 
prepared freshly on the day of the experiment. Animals were 
treated with the vehicle or extract/standard 1 h before 
commencement of the experiments. 
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2.7. Tests for Analgesic Activity 
2.7.1. Hot Plate Test  
For the hot plate test, following the administration according 
to the grouping, mice were placed on a hot-plate set at 55 ± 
0.5 °C. The latency of nociceptive response like when the 
mice licking their fore- and hind paws or jumping or flicking 
were recorded at different times after oral administration of 
the extract or control (5 mg/kg morphine or vehicle (2% 
Tween 80). Latency time or reaction time (in seconds) on 
the hot plate for each mouse was determined at time 0 
before and intervals of 30, 60, 90 and 120 minutes after 
treatment with the respective agent. A cut of period of 15 
seconds was given to avoid damage to the paw. Percentage 
latency (% Latency) and Maximum Possible Analgesia (% 
MPA), was calculated for each group as shown below.20 
Percentage latency obtained by using this formula: 
 
           
                                               
                                
        
Percentage Maximum Possible Analgesia (% MPA) obtained by using this formula: 
      
                              
                        
        
 
2.7.2. Acetic acid Induced Writhing Test  
This test was performed as described by Koster et al., 1959 
cited by Chattopadhyay et al., 2012.21 Mice were treated as 
described under grouping and dosing and one hour 
following treatment, mice received I.P. injection of 0.6% v/v 
acetic acid solution at a dose of 10 ml/kg. Five minutes after 
administration of acetic acid, the number of writhes or 
stretches (a syndrome, characterized by a wave of 
contraction of the abdominal musculature followed by 
extension of hind limbs) was counted for 15 min.22 A 
reduction in the number of writhes as compared to the 
control group was considered as evidence for the presence 
of analgesia, expressed as percent inhibition of writhing, 
which calculated according to the following formula: 
            
  
                                 
                            
        
2.8. Preliminary phytochemical screening  
The hydro-alcoholic extract of S. incanum leaves was 
screened according to Trease and Evans (1996), cited by 
Musa et al., 2009, for its secondary metabolites according to 
standard procedures.23, 24 
2.9. Statistical Analysis  
Results was expressed as mean ± standard error of mean 
(SEM) of responses. The results were analyzed statistically 
using SPSS Software Ver.20. The statistical significance was 
determined using One-way Analysis of Variance (ANOVA) 
followed by Tukey post Hoc test. The value, p<0.05 was 
considered as statistically significant. 
3. RESULT  
3.1. Acute toxicity study  
The acute toxicity study indicated that the leaf extract of S. 
Incanum at a dose of 2000 mg/kg caused no mortality within 
the first 24 h and for the next 14 days. Physical and 
behavioral observations of the experimental mice also 
revealed no visible overt signs of acute toxicity like skin and 
fur, eyes and mucous membranes, and also respiratory, 
circulatory, autonomic and central nervous systems, and 
somatomotor activity and behavior pattern. The data 
suggest that LD50 of the leaf extract is more than 2000 
mg/kg. 
3.2. Hot plate test  
The effect of 80% methanolic extract of S. incanum on the 
hot plate test is presented in Table 1. Accordingly, all doses 
of the extract and the standard drug of morphine produced 
significant central analgesic effect by increasing the latency 
time as compared with negative control. The increase in 
latency was significantly higher (p< 0.01) for extract and 
morphine as compared with the negative control in all times 
of latency measurement. However, there was no significant 
difference in latency period between the extract and the 
standard drug. In addition, there was no significant 
difference in latency between different doses of the extract. 
 
Table 1: Effect of 80% methanol leaf extract of S. incanum on the hot plate test 
Group Mean Latency time (sec) ±S.E.M 
0 Min 30 Min 60 Min 90 Min 120 Min 
Neg. con 5.67±1.542 5.17+.910 5.17+0.946 5.67+1.783 5.33+2.140 
MOR (5mg/kg)  6.33±1.856 13.50+0.719 a3 11.67+1.585 a2 13.17+0.792 a2 13.17+0.792 a2 
100mg/kg  4.17±.601 12.83+.872 a3 12.33+1.229 a2 11.00+1.291 a1 10.83±0.792 a1 
200 mg/kg 4.33+.333 11.17+1.537 a2 11.50+0.92 a2 13.33+0.955 a2 13.00+0.730 a2 
400 mg/kg 7.17+1.579 11.33±1.202 a2 14.17+0.833 a3 12.67+1.054 a2 13.17+1.014 a2 
Data represent mean ± S.E.M (n = 6); 1=p<0.05, 2=p<0.01, 3=p<0.001; a: relative to control MOR - morphine 5 mg/kg; data in 
parenthesis show percentage increase in latency of licking relative to time zero within individual group. 
 
As shown in table 2 the extract at a dose of 200 and 400 
mg/kg has resulted in 143.9% and 174.08 % increase in 
latency at 120 and 60 min respectively compared to the 
negative control. In addition, the middle dose of the extract 
has resulted in percent increase in latency of 143.9% at 120 
min. Furthermore, the positive control morphine has caused 
significantly different analgesia effect at 30 min resulting in 
161.12% of increase in latency  but less than the higher dose 
of the extract at 60 min (174.08%). 
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Table 2: The Percent latency (% latency) effects of S.incanum 80% methanol extract 
Mean Percent Latency (%) 
Group                                                    30 min                                60 min                                90 min                                120 min  
Neg. CON      
MOR  161.12 125.7 132.3 147 
100mg/kg  148.2 138.5 94.00 103.2 
200mg/kg  116.05 122.4 135.09 143.9 
400mg/kg  119.14 174.08 123.5 147.09 
 
 
In addition, Fig 1 depicts percentage increase in reaction 
time across the observation period. Time to peak activity 
was longer for the extract (60 min) than for the standard 
drug (30 min). 100 mg/kg of the extract protection waned 
across time. By contrast, the change for 200 mg/kg 
somewhat increases with increase in observation time 
except for the 120 min time. The trend with 400 mg/kg was 
different, showing both increase and decrease in latency at 
different intervals. 
 
Figure 1:  Percent increase in latency time for 80 % 
methanol extract of S.incanum 
3.3. Acetic acid induced writhing test  
As it is depicted in Table 3, mice treated with 80% methanol 
extract of S.incanum showed a significant protection 
(p<0.05) against acetic acid induced writhing compared to 
negative control group. Even if the positive control ASA and 
extract (100, 200 and 400mg/kg) produced comparable 
protection, aspirin resulted in the superior percent 
inhibition than all test doses of the extract. The 80% 
methanol extract of S.incanum produced a significant 
analgesic activity with 55.6, 38.2 and 44.8% inhibition of 
number of writhing at 100, 200 and 400 mg/kg dose levels, 
respectively. 
Table 3: Effect of 80% methanol leaf extract of S. incanum 
on the hot plate test in acetic acid induced writhing test 
model 
Group                            Mean                      %Inhibition 
Neg. CON  63.40±3.187  
Aspirin  23.50±4.945 a3 62.9 
100mg/kg 28.17±6.041 a3 55.6 
200mg/kg 39.17±5.522 a1 38.2 
400mg/kg 35.00±6.623 a1 44.8 
Data represent mean ± S.E.M and percent inhibition of 
number of writhing with respect to the negative control, (n = 
6); 1=p<0.05, 2=p<0.01, 3=p<0.001; a 
3.4. Phytochemical Screening 
The results of phytochemical screening test showed the 
presence of different secondary metabolites in hyro-
alcoholic extract of S.incanum. Whilst alkaloids, tannins, 
saponins, phenolic compounds, terpenoids, and flavonoids 
were detected, steroids were not found in the extract.  
4. DISCUSSION  
The presented study revealed that the 80 % extract of 
S.incanum have analgesic activity in hot plate and acetic acid 
induced writhing tests. Hot plate tests are the most common 
tests of central nociceptive activity that are based on a 
phasic stimulus of high intensity. Pain induced by thermal 
stimulus of the hot plate is specific for centrally mediated 
activity. They were selected for this study because of several 
advantages including sensitivity to strong analgesics, limited 
tissue damage, accuracy of results and they are also less time 
consuming.25 In the hot plate method, a plate heated at a 
constant temperature produces two behavioral components 
that can be measured in terms of their reaction times, 
namely paw licking and jumping. Both are considered to be 
supra-spinally integrated responses. As far as analgesic 
substances are concerned, the paw-licking behavior is 
affected only by opioids. On the other hand, the jumping 
reaction time is increased equally by less powerful 
analgesics such as acetylsalicylic acid or Paracetamol.26 
The peak increase in the latency time was observed at 30 
min of interval in the hot plate test for the 100 mg/kg of the 
extract and the standard drug Morphine in the present 
study. However the middle and the higher dose of the extract 
have shown peak latency at 90 and 60 min interval 
respectively. This difference could be attributed the time lag 
between drug entering the central compartment and 
distribution into the target site or formation of an active 
metabolites that are endowed with analgesic activity. The 
lower dose have shown time dependent decrease in its 
analgesic activity which could be explained by the decrease 
in the concentration of the active compounds in the brain 
with time but the 200 and 400 mg/kg doses have relatively 
long lasting analgesic effect throughout the time intervals.  
Similar studies have also shown comparable analgesic 
activity of different plant extracts in the hot plate model. For 
example, according to Abiye et al, 2019, evaluation of the 
extract of H. revolutum leaves in the hot plate test showed 
significant central analgesic effect. This was demonstrated 
by increase in latency time or increase in threshold of pain 
by thermal stimuli.27 In addition, a study done by Nasrin et 
al., 2017 showed that Solanum sisymbriifolium was have got 
moderate but significant antinociceptive activity of 
particularly at higher dose (400 mg/kg). The effect was 
more profound in heat-induced pain models than chemical 
induced model showing the central antnociceptive activity of 
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indicated that Rosa damascena extract was demonstrated to 
increase in latency time or increase in threshold of pain by 
thermal stimuli.29 
The effect of the extract hot plate method provides a 
confirmation of its central effect. S.incanum showed a central 
anti nociceptive activity by increasing the latency to 
discomfort and may act like centrally active drugs, by 
activating the periaqueductal grey matter to release 
endogenous peptides (i.e., endorphin or enkephalin). These 
endogenous peptides descend to spinal cord and function as 
inhibitors of the pain impulse transmission at the synapse in 
the dorsal horn.30 
Acetic acid-induced abdominal constriction method was 
employed to evaluate peripheral antinociceptive activity 
because it is very sensitive and able to detect antinociceptive 
effects of compounds at dose levels that may appear inactive 
in other methods. Although, acetic acid-induced writhing is a 
highly sensitive and useful test for analgesic drug 
development but not a selective pain test as it gives false 
positive result with sedatives, muscle relaxants. 
Intraperitoneal injection of acetic acid produces pain 
through activation of chemosensitive nociceptors or 
irritation of the visceral surface, which lead to the liberation 
of histamine, bradykinin, prostaglandins and serotonin.31  
The present results showed that the 80% methanolic extract 
of S.incanum induced analgesic effect against the writhing 
syndrome indicating its peripheral effect. Prolongation of 
reaction time produced by 200, and 400mg/kg of the extract 
was significantly lower compared to Aspirin at all-time 
points. But 100 mg/kg of has comparable effects with 
Aspirin. The S.incanum extract at all test doses significantly 
reduced the writhing response while the lower dose was 
superior in its action compared to the other doses. This may 
be explained by the difference in the pharmacokinetics of 
constituents of the plant extract. So, the higher dose has 
more central distribution and has greater central effect as 
seen in the hot plate test but the lower dose has greater 
peripheral effect. Similar study by Maniyor et al. who has 
evaluated the extracts derived from leaves of S. melongena 
Linn. exhibited significant analgesic activity in albino rats by 
inhibiting acetic acid induced writhing, which is a model of 
visceral pain.31  
In peripheral tissues, prostaglandins and kinines would 
seem to play an important role in the pain process and 
writhing induced by chemical substances injected intra-
peritoneally is said to be the consequence of sensitization of 
the chemosensitive nociceptors by prostaglandins.32 This 
response is characterized by abdominal contractions 
accompanied by movements of the hind paws particularly. 
The writhing response is due to sensitization of 
chemosensitive nociceptors by prostagl and insparticularly 
PGE2 and PGF2 as well as lipoxygenase products.33, 34 These 
results suggest that the pain killing effect of this plant may 
be by the prostaglandins synthesis inhibition. This test also 
confirms the peripheral action of Aspirin. 
The analgesic effect of 80% methanolic extracts of S 
.incanum may be attributed to the presence of different 
phytoconstituents. Preliminary phytochemical screening in 
this study have shown the have indicated that the leaves of S 
.incanum have different secondary metabolites like 
terpenoids, alkaloids, flavonoids, saponins, tannins and 
phenolic compound which was almost similar with a study 
done by Manal et al., 2017.17 The leaves of S.incanum were 
extracted with 80% methanol using maceration technique. 
Methanol is a universal, safe and effective solvent in 
extracting polar and less polar secondary metabolites. It is a 
preferable solvent in extracting semi-polar compounds (e.g., 
phenolic acids, flavonoids, and alkaloids) from different 
parts of medicinal plants. It is also a best solvent to get the 
highest phenolic and flavonoid contents, followed by 80% 
ethanol, 80% acetone and distilled water.9 
The secondary metabolites obtained in this plant extract 
have been reported to have different extents of analgesic 
activities. For instance, alkaloids exert their analgesic action 
by interfering with the CNS neurotransmitter activity.35 
Flavonoids and saponins are well known for their ability to 
inhibit pain perception as well as anti-inflammatory 
properties due to their inhibitory effects on enzymes 
involved in the production of the chemical mediator of 
inflammation. Flavonoids may also increase the amount of 
endogenous serotonin or may interact with 5-HT2A and 5-
HT3 receptors, which may be involved in the mechanism of 
central analgesic activity. Flavonoids are also found to target 
the prostaglandins, which are involved in the late phase of 
acute inflammation and pain.36 Thus, in the 80% methanol 
leaf extract of S .incanum, flavonoids could contribute to 
suppression of activation and sensitization of peripheral 
chemo-sensitive nociceptors by acetic acid and both 
alkaloids and flavonoids could contribute for the central 
effect in the hotplate test. 
5. CONCLUSION  
In conclusion, the results obtained in the present study 
clearly suggest that 80% Methanol leaf extract of S. incanum 
is endowed with significant central and peripheral analgesic 
activity as shown by increase in latency in hot plate test and 
protection against acetic acid induced writhing tests. Hence, 
the findings collectively uphold the traditional use of the 
plant for wound treatment. 
Acknowledgement: The authors acknowledge Addis 
Ababa University for financing the study. 
Disclosure of Conflict of Interest: The authors have not 
declared any conflict of interests.  
REFERENCES 
1. Williams AC, Craig KD, Updating the definition of pain, Pain, 
2016, 157 (11):2420–3.  
2. Fink R, Pain assessment: the cornerstone to optimal pain 
management, Baylor University Medical Center Proceedings, 
2000, 13(3):236–9. 
3. Swieboda P, Filip R, Prystupa A, Drozd M, Assessment of pain: 
types, mechanism and treatment, Annals of Agriculutural and 
Environmental Medicine, 2013; 1:2–7. 
4. Raffaeli W, Arnaudo E, Pain as a disease: an overview, Journal 
of Pain Research. 2017, 10: 2003–8. 
5. Morris LD, Daniels KJ, Ganguli B, Louw QA, An update on the 
prevalence of low back pain in Africa: a systematic review and 
meta-analyses, BMC Musculoskeletal Disorders 2018, 
19(1):1–15. 
6. Mengistu G, Alemayehu S, Prevalence and burden of primary 
headache disorders among a local community in Addis Ababa, 
Ethiopia, The Journal of Headache and Pain, 2013, 14(1): 30. 
7. James MW, Hawkey CJ, Assessment of non-steroidal anti-
inflammatory drug (NSAID) damage in the human 
gastrointestinal tract, British Journal of Clinical 
Pharmacology, 2003, 56(2):146–55.  
8. Kaushik D, Kumar A, Kaushik P, Rana AC, Analgesic and Anti-
Inflammatory Activity of Pinus roxburghii Sarg, Advances in 
Pharmacological Sciences, 2012: 245431.  
9. Saikat Sen RC, Analgesic and anti-inflammatory herbs: a 
potential source of modern medicine, International journal of 
pharmaceutical sciences and research, 2019.  
10. Quibria T, Das B, Hasan T, Azim Uddin M, Alam MM, 
Phytochemical screening and evaluation of analgesic activity 
of Solanum surattense, American Journal of Pharmaceutical 
Sciences and Nanotechnology, 2014, 1(1): 1-10.  
11. Parsaei DrP, Bahmani M, Karimi M, Naghdi N, Asadi-Samani M, 
Rafieian-kopaei M, A review of analgesic medicinal plants in 
Iran. Der Pharmacia Lettre, 2016, 8 (2):43-51.  
Abera et al                                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(5):9-14 
ISSN: 2250-1177                                                                                  [14]                                                                                 CODEN (USA): JDDTAO 
12. Marmitt D, Bitencourt S, Silva A, Goettert M, Rempel C, 
Medicinal plants of Renisus with analgesic activity, Journal of 
Critical Reviews, 2016, 3(3):1-4.  
13. Abdalla IMF, Leaves value of Solanum incanum L. at Khartoum 
North-Sudan, International Journal of Engineering Science 
and Innovative Technology, 2015, 4(1):25–28.  
14. Mwonjoria JK, Ngeranwa JJ, Kariuki HN, Githinji CG, Sagini MN, 
Wambugu SN, Ethno medicinal, phytochemical and 
pharmacological aspects of Solanum incanum (lin.). 
International Journal of Pharmacology and Toxicology, 2014, 
5:2(2):17–20.  
15. Bussmann RW, Gilbreath GG, Solio J, Lutura M, Lutuluo R, 
Kunguru K, et al, Plant use of the Maasai of Sekenani Valley, 
Maasai Mara, Kenya. Journal of Ethnobiology and 
Ethnomedicine, 2006, 5:2:22.  
16. Teklehaymanot T, Ethnobotanical study of knowledge and 
medicinal plants use by the people in Dek Island in Ethiopia, 
Journal of Ethnopharmacology, 2009, 124(1):69–78.  
17. Manal A.H, Eltohami M.S.,Ghada M.Ahmad, The phytochemical 
screening and antimicrobial activity of Solanum incanum L., 
International Journal of innovative Pharmaceutical sciences 
and research, 2016, 4(2):87-92.  
18. Mwonjoria JK, Ngeranwa J, Githinji C, Kahiga T, Kariuki H, 
Waweru F, Suppression of nociception by Solanum incanum 
(Lin.) Diclomethane root extract is associated anti-
inflammatory activity, The Journal of Phytopharmacology. 
2014; 3(3):156–62. 
19. OECD, Test No. 425: Acute Oral Toxicity: Up-and- Down 
Procedure, OECD Publishing, 2008.  
20. Debebe E., MakonnenE.andDebella A.(2007). Anti-nociceptive 
effect of the methanolic extract of roots of andrachneaspera in 
three models of nociception, Pharmacology online 1: 41-48. 
21. Chattopadhyay C, Chakrabarti N, Chatterjee M, Chatterjee S, 
Bhattacharyay D, Ghosh D (2012). Evaluation of acute anti-
inflammatory and analgesic activities of green tea decoction 
on experimental animal models. Int J Nutr Pharma Neurol Dis 
2: 20-5. 
22. Jayanthi MK and Jyoti MB, Experimental animal studies on 
analgesic and anti-nociceptive activity of Allium Sativum 
(Garlic) powder, Indian journal of research and reports in 
medical sciences, 2012, 2(1): 1-6. 
23. World Health Organization, The promotion and development 
of traditional medicine, Technical Report Series, Geneva, 
1978: 622. 
24. Musa AM, Aliyu AB, Yaro AH, Magaji MG, Hassan HS, Abdullahi 
MI, Preliminary phytochemical, analgesic and anti-
inflammatory studies of the methanol extract of 
Anisopusmannii (N.E.Br) (Asclepiadaceae) in rodents, African 
Journal of Pharmacy and Pharmacology, 2009, 3(8):374-378 
25. Sharma V, Paliwal DrR, Dr. Pracheta, Sharma C, 
Antinociceptive activity of hydro ethanol extract from 
Moringa oleifera (Moringaceae) pods in Swiss albino mice, 
Internationale Pharmaceutica Siencia, 2012 2(3):54 
26. Milind P, Monu Y, Laboratory models for screening analgesics. 
International research Journal of pharmacy, 2013; 4(1):5.  
27. Abiye A, Tadesse W, Assefa S, Hailu A. Evaluation of Analgesic 
and Anti-Inflammatory Activities of hydro-alcoholic leaf 
extract of Hypericum revolutum in Mice. International journal 
of biomedical research, 2019, 10(03): e5071. 
28. Nasrin T, Khandaker M, Akter S, Imam MZ, Antinociceptive 
activity of methanol extract of leaves of Solanum 
sisymbriifolium in heat and chemical-induced pain, Journal of 
Applied Pharmaceutical Science, 2017; 7(11):142–146.  
29. Hajhashemi V, Ghannadi A, Hajiloo M, Analgesic and Anti-
inflammatory Effects of Rosa damascena Hydroalcoholic 
Extract and its Essential Oil in Animal Models, Iranian Journal 
of Pharmaceutical Research, 2010, 9(2):163.  
30. Milind P. and Monu Y, Laboratory models for screening 
analgesics. International Research Journal of Pharmacy, 2013, 
4: 15-19. 
31. Maniyar YA, Evaluation of analgesic activity of aqueous 
extract of leaves of solanum melongena linn in experimental 
animals, Asian Journal of Pharmaceutical and clinical 
research. 2015, 8(1):4.  
32. Ndebia E, Kamgang R, N Nkeh-ChungagAnye B, Analgesic and 
Anti-Inflammatory Properties of Aqueous Extract from Leaves 
of Solanum torvum (Solanaceae), African Journal of 
Traditional, Complementary and Alternative Medicines, 2007, 
4 (2): 240-244. 
33. Le Bars D, Gozariu M, Cadden S, Animal Models of 
Nociception, The American Society for Pharmacology and 
Experimental Therapeutics, 2002: 53 (4):597-652.  
34. Bhattacharya A, Agrawal D, Sahu PK, Kumar S, Mishra SS, 
Patnaik S, Analgesic effect of ethanolic leaf extract of Moringa 
oleifera on albino mice, Indian Journal of Pain, 2014, 1: 
28(2):89. 
35. Reanmongkol W, Subhadhirasakul S, Thienmontree S, 
Thanyapanit K, Kalnaowakul J and Sengsui S, Anti-nociceptive 
activity of the alkaloid extract from Kopsia macrophylla leaves 
in mice, Journal of Science and Technology, 2005, 27:509-516. 
36. Kaushik D, Kumar A, Kaushik P, Rana AC (2012). Analgesic 
and anti-Inflammatory Activity of Pinusroxburghii Sarg, 
Advances in Pharmacological Sciences, 2012(1):245431.
 
 
 
 
 
